Synflex-M Tablet

Synflex-M

Synflex-M Tablet

Naproxen

Martin Dow Pharmaceuticals (Pvt) Ltd.

Drug Identity

Active Ingredient
Naproxen
Drug Class
Antimigraine Preparations
0

How to Take It

Dosage information not available for this product.

Safety Alerts

Coronary vasospasm, ischaemic heart disease, uncontrolled, moderate and severe hypertension, peripheral vascular disease, previous cerebrovascular accident, previous myocardial infarction, previous transient ischaemic attack, Prinzmetals angina, active GI bleeding or ulceration or haemorrhage (two or more distinct episodes), severe heart failure, NSIAD induced allergy, hepatic and renal failure

Important Warnings

Predisposition to coronary artery disease, asthma, elderly, history of seizures, mild controlled hypertension, pre-existing cardiac disease, risk factors for seizures, renal or hepatic impairment (reduce dose), allergic disorders

Side Effects

Anxietyarthralgiabradycardiadiarrhoeadizzinessdrowsinessraised blood pressuredyspneafatigueflushingmyalgianauseasensory disturbancestransient increase in blood pressurevomiting

Drug Interactions

MAOIs
ergotamine
SSR1s
St. Johns Wort
anticoagulants
antiplatelets
hydantoins
sulfo-nylureas

Pregnancy & Lactation

Pregnancy
Avoid unless the potential benefit outweighs the risk.
Lactation
Withhold breast-feeding for 12 hours after treatment.

Price Intelligence

Rs 460
DVAGO observed price · as of 30 July 2026
DRAP approved ceiling: Rs 262.32 (per unit)
Pack size is not recorded for both figures, so we do not compare them here.
Reg. 083167 · approved 01 Jul, 2024
Prices across sources
DVAGORs 460
ServaidRs 270

Should you consider an alternative?

Other options containing Naproxen, and what they are not.

These contain this ingredient plus others. They are different medicines — do not swap.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.